At a glance
The FY26 Alzheimer’s Transforming Care Award supports clinical research and clinical trials on interventions, innovations, and solutions for dementia care for people with Alzheimer’s disease and related dementias and their care partners. Eligible applicants include U.S. Department of War organizations and other U.S. organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities; awards go to organizations, not individuals. The program expects to fund about three awards with roughly $5.4 million total, with a maximum of $1.6 million in total costs for a single-PI application or $1.9 million combined for the CIT Partnership Option, over up to 4 years. Cost sharing is not required. Community collaboration is required for studies that prospectively enroll human subjects, and clinical trials that only test or evaluate pharmacological interventions, animal studies, and travel beyond the stated meeting limits are not allowed.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research or clinical trials evaluating interventions, innovations, and solutions in critical areas for dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementia (AD/ADRD) and their care partner(s). Distinctive Features: Clinical research and clinical trials are allowed; however, clinical trials solely testing or evaluating pharmacological interventions do not meet the intent of this funding opportunity. Studies utilizing animal models do not meet the intent of the mechanism and are not allowed. Preliminary data are required. Community collaboration is required for research prospectively enrolling human subjects. The AZRP encourages studies to leverage existing cohorts/datasets. Cohorts consisting of individuals 65 years or younger are also encouraged. Career Initiation or Transition (CIT) Partnership Option: The TrCA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet the CIT Partnership Option eligibility requirements at the time of application submission.
Who can apply
- Unrestricted